Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben Prins

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal for Immunotherapy of Cancer|August 19, 2025
HPV16 E6 and E7 expressing cancer cells suppress the antitumor immune response by upregulating KLF2-mediated IL-23 expression in macrophagesRuben Prins, Daniel J Fernandez, Omid Akbari, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
WAVE1 and WAVE2 facilitate human papillomavirus-driven actin polymerization during cellular entryD J Fernandez, Stephanie Cheng, Ruben Prins, et al.
Viruses|April 26, 2025
Human Papillomavirus Type 16 Stimulates WAVE1- and WAVE2-Dependent Actin Protrusions for Endocytic EntryDaniel J Fernandez, Stephanie Cheng, Ruben Prins, et al.
Cancers|February 27, 2026
Targeting STAT3 Promotes Tumor Cell Death and Enhances T-Cell Activity in HPV16-Positive CancerRuben Prins, Daniel J Fernandez, Diane M Da Silva, et al.
Frontiers in Immunology|June 6, 2020
TNFSF14: LIGHTing the Way for Effective Cancer ImmunotherapyJoseph G Skeate, Mikk E Otsmaa, Ruben Prins, et al.
Frontiers in Immunology|November 6, 2020
Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid ClusteringJoseph G Skeate, Wouter H Segerink, Mauricio D Garcia, et al.
Scientific Reports|January 11, 2018
Development and characterization of a novel luciferase based cytotoxicity assayHittu Matta, Ramakrishnan Gopalakrishnan, Sunju Choi, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
NTX250: A Modular mRNA-Based Immunotherapy Platform for HPV-Associated Cancers with Broad ApplicabilityMeredith L Leong, Weiqun Liu, Nicole Fay, et al.
Scientific Reports|February 15, 2019
A novel luciferase-based assay for the detection of Chimeric Antigen ReceptorsRamakrishnan Gopalakrishnan, Hittu Matta, Sunju Choi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal for Immunotherapy of Cancer|August 19, 2025
HPV16 E6 and E7 expressing cancer cells suppress the antitumor immune response by upregulating KLF2-mediated IL-23 expression in macrophagesRuben Prins, Daniel J Fernandez, Omid Akbari, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
WAVE1 and WAVE2 facilitate human papillomavirus-driven actin polymerization during cellular entryD J Fernandez, Stephanie Cheng, Ruben Prins, et al.
Viruses|April 26, 2025
Human Papillomavirus Type 16 Stimulates WAVE1- and WAVE2-Dependent Actin Protrusions for Endocytic EntryDaniel J Fernandez, Stephanie Cheng, Ruben Prins, et al.
Cancers|February 27, 2026
Targeting STAT3 Promotes Tumor Cell Death and Enhances T-Cell Activity in HPV16-Positive CancerRuben Prins, Daniel J Fernandez, Diane M Da Silva, et al.
Frontiers in Immunology|June 6, 2020
TNFSF14: LIGHTing the Way for Effective Cancer ImmunotherapyJoseph G Skeate, Mikk E Otsmaa, Ruben Prins, et al.
Frontiers in Immunology|November 6, 2020
Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid ClusteringJoseph G Skeate, Wouter H Segerink, Mauricio D Garcia, et al.
Scientific Reports|January 11, 2018
Development and characterization of a novel luciferase based cytotoxicity assayHittu Matta, Ramakrishnan Gopalakrishnan, Sunju Choi, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
NTX250: A Modular mRNA-Based Immunotherapy Platform for HPV-Associated Cancers with Broad ApplicabilityMeredith L Leong, Weiqun Liu, Nicole Fay, et al.
Scientific Reports|February 15, 2019
A novel luciferase-based assay for the detection of Chimeric Antigen ReceptorsRamakrishnan Gopalakrishnan, Hittu Matta, Sunju Choi, et al.
Pageof 1